Loading organizations...
Loading organizations...
Biotechnology company developing therapies for neurodegenerative diseases.
Proclara Biosciences has raised $101.8M across 6 funding rounds.
Proclara Biosciences has raised $101.8M in total across 6 funding rounds.
Proclara Biosciences has raised $101.8M in total across 6 funding rounds.
Proclara Biosciences's investors include Merieux Equity Partners, Valerie Calenda, Shire, Michael Heartlein.
Proclara Biosciences has raised $101.8M across 6 funding rounds. Most recently, it raised $47.0M Series E in September 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 7, 2016 | $47.0M Series E | Merieux Equity Partners | |
| Jan 14, 2015 | $10.0M Series D Extension | ||
| Mar 25, 2014 | $17.0M Series D | ||
| May 6, 2013 | $6.4M Other Equity | Valerie Calenda | Shire |
| Mar 8, 2012 | $9.0M Series B | ||
| Mar 1, 2011 | $12.4M Series B | Valerie Calenda | Michael Heartlein |